论文部分内容阅读
目的探讨麦默通旋切术在乳腺肿块患者治疗中的临床效果。方法选取2013年1月至2015年12月间南京医科大学附属常州第二人民医院收治的95例乳腺肿块患者,根据治疗方式不同分为观察组(55例)和对照组(40例),观察组患者行麦默通微创穿刺及旋切术,对照组患者行常规盲探穿刺及传统开放手术。比较两组患者临床手术切除率、确诊率、穿刺耗时、术中出血量及手术相关并发症。结果观察组患者临床手术切除率为98.2%高于对照组患者的75.0%,观察组患者确诊率为98.2%,高于对照组的47.5%,差异均有统计学意义(均P<0.05)。观察组患者穿刺耗时短于对照组,术中出血量少于对照组,差异均有统计学意义(均P<0.05)。观察组患者各不良反应发生率均低于对照组,差异均有统计学意义(均P<0.05)。结论乳腺肿块患者行麦默通微创旋切,能有效提高诊断率,缩短操作时间,减少操作中出血量,减少并发症。
Objective To investigate the clinical effect of mesomectomy in the treatment of patients with breast lumps. Methods Ninety-five patients with breast masses admitted to Changzhou Second People’s Hospital Affiliated to Nanjing Medical University from January 2013 to December 2015 were selected and divided into observation group (55 cases) and control group (40 cases) according to different treatment methods. Group patients were treated with minimally invasive puncturation and revascularization. Patients in the control group underwent conventional blind blind puncture and conventional open surgery. The clinical resection rate, the diagnosis rate, the time spent on puncture, the amount of intraoperative blood loss and operation-related complications were compared between the two groups. Results The surgical resection rate in the observation group was 98.2% higher than 75.0% in the control group. The diagnosis rate in the observation group was 98.2%, which was significantly higher than that in the control group (47.5%, both P <0.05). The patients in the observation group took less time to puncture than those in the control group, and the amount of bleeding in the observation group was less than that in the control group (all P <0.05). The incidence of adverse reactions in the observation group was lower than that in the control group, the differences were statistically significant (P <0.05). Conclusions The patients with breast lumps underwent minimally invasive rotomolision, which can effectively improve the diagnostic rate, shorten the operation time, reduce the amount of bleeding during operation and reduce the complications.